PDF下载 ( 1931 KB)
Chinese expert consensus on treatment of pancreatic cancer by radioactive 125I particle implantation (2017)
-
摘要:
<正>中国是胰腺癌高发区域(本共识所指胰腺癌是指起源于胰腺导管上皮的恶性肿瘤,包括导管腺癌、腺鳞癌、胶样癌等),发病率整体呈上升趋势,>65岁老年人的胰腺癌发病率已达到高发国家水平,1998年至2007年统计资料显示城市男性粗发病率每年以1.86%的比例上升,女性粗发病率每年上升2.1%;20世纪70年代,死于胰腺癌的病例相对少见,第1次全国死因回顾抽样调查没有单列,20世纪90年代第2
-
Key words:
- pancreatic neoplasms /
- iodine radioisotopes /
- therapy /
- consensus
-
[1]MA C, JIANG YX, LIU SZ, et al.Trend and prediction on the incidence of pancreatic cancer in China[J].Chin J Epidemiol, 2013, 34 (2) :160-163. (in Chinese) 马臣, 姜永晓, 刘曙正, 等.中国胰腺癌发病趋势分析和预测[J].中华流行病学杂志, 2013, 34 (2) :160-163. [2]GU K, WU CX, BAO PP, et al.Incidence of pancreatic cancer in Shanghai:a current, retrospective and comparative exploration[J].J Surg Concepts Pract, 2009, 14 (5) :510-515. (in Chinese) 顾凯, 吴春晓, 鲍萍萍, 等.上海市胰腺癌流行现况、回顾与比较分析[J].外科理论与实践, 2009, 14 (5) :510-515. [3]CHEN Z.The third national death survey report[M].Beijing:Peking Union Medical College Publication House, 2008. (in Chinese) 陈竺.全国第三次死因回顾抽样调查报告[M].北京:中国协和医科大学出版社, 2008. [4]ZHANG WD, MIAO SJ.Analysis on epidemic characteristics of cancer death rate in China[J].Chin J Health Education, 2009, 25 (4) :246-248. (in Chinese) 张伟东, 苗树军.我国恶性肿瘤死亡率流行病学特征分析[J].中国健康教育, 2009, 25 (4) :246-248. [5]SIEGEL R, NAISHADHAM D, JEMAL A.Cancer statistics, 2013[J].CA Cancer J Clin, 2013, 63 (1) :11-30. [6]MULDER I, HOOGENVEEN RT, van GENUGTEN ML, et al.Smoking cessation would substantially reduce the future incidence of pancreatic cancer in the European Union[J].Eur J Gastroenterol Hepatol, 2002, 14 (12) :1343-1353. [7]ZHANG QH, NI QX.Clinical analysis of 2340 cases of pancreatic cancer[J].Natl Med J China, 2004, 84 (3) :214-218. (in Chinese) 张群华, 倪泉兴.胰腺癌2340例临床病例分析[J].中华医学杂志, 2004, 84 (3) :214-218. [8]JIN G, SHAO Z, HU XG, et al.Efficacy and prognosis analysis of2061 cases of pancreatic cancer resection[J].Chin J Pancreatol, 2013, 13 (1) :1-4. (in Chinese) 金钢, 邵卓, 胡先贵, 等.胰腺癌2061例外科手术的疗效与预后分析[J].中华胰腺病杂志, 2013, 13 (1) :1-4. [9]PERETZ T, NORI D, HILARIS B, et al.Treatment of primary unresectable carcinoma of the pancreas with I-125 implantation[J].Int J Radiat Oncol Biol Phys, 1989, 17 (5) :931-935. [10] Notice of the General Office of the National Health and Family Planning Commission on issuing 15 administrative regulations on medical technology management practices and quality control indicators including the Management of Hematopoietic Stem Cell Transplants (2 0 1 7 Edition) [EB/OL].http://www.moh.gov.cn/yzygj/s3585/201702/e1 b8 e0 c9 b7 c841 d49 c1895 ecd475d957.shtml. (in Chinese) 国家卫生计生委办公厅关于印发造血干细胞移植技术管理规范 (2017年版) 等15个“限制临床应用”医疗技术管理规范和质量控制指标的通知[EB/OL].http://www.moh.gov.cn/yzygj/s3585/201702/e1b8e0c9b7c841d49c1895ecd475d957.shtml. [11] Committee of Experts on Radioactive Particle Implantation Technology, Chinese Medical Doctor Association, CSCO Tumor Minimally Invasive Treatment Committee, Particle Therapy Branch.Regulations on radioactive particle implantation treatment (2017 Edition) [J].Natl Med J China, 2017, 97 (19) :1450-1451. (in Chinese) 中国医师协会放射性粒子植入技术专家委员会, 中国抗癌协会肿瘤微创治疗专业委员会粒子治疗分会.放射性粒子植入治疗技术管理规范 (2017年版) [J].中华医学杂志, 2017, 97 (19) :1450-1451. [12]HU XK, ZHANG FJ.Regulations and interpretations of radioactive particle implantation technology[J].Natl Med J China, 2017, 97 (19) :1441-1443. (in Chinese) 胡效坤, 张福君.国家限制类医疗技术放射性粒子植入治疗技术管理规范及临床应用质量控制指标解读[J].中华医学杂志, 2017, 97 (19) :1441-1443. [13] Committee of Experts on Radioactive Particle Implantation Technology, Chinese Medical Doctor Association, CSCO Tumor Minimally Invasive Treatment Committee, Particle Therapy Branch.Quality control index for radioactive particle implantation (2017 Edition) [J].Natl Med J China, 2017, 97 (19) :1452-1454. (in Chinese) 中国医师协会放射性粒子植入技术专家委员会, 中国抗癌协会肿瘤微创治疗专业委员会粒子治疗分会.放射性粒子植入治疗技术临床应用质量控制指标 (2017年版) [J].中华医学杂志, 2017, 97 (19) :1452-1454. [14] CSCO Tumor Minimally Invasive Treatment Committee, Particle Therapy Branch.Ward radiation protection from radioactive125I particle:expert consensus on management standards[J].Natl Med J China, 2017, 97 (19) :1455-1456. (in Chinese) 中国抗癌协会肿瘤微创治疗专业委员会粒子治疗分会.放射性125I粒子病房辐射防护管理标准专家共识[J].中华医学杂志, 2017, 97 (19) :1455-1456. [15] GAI BD, DING DY, SHU ZB, et al.Realized the operative experience of iodine-125 brachytherapy for pancreatic cancer[J].J Endocr Surg, 2007, 1 (4) :234-235, 238. (in Chinese) 盖宝东, 丁大勇, 舒振波, 等.125I放射性粒子治疗在胰腺癌术中应用[J].内分泌外科杂志, 2007, 1 (4) :234-235, 238. [16]LYU ZW, GAI BD, YANG DY.Interstitial implantation of125I seeds for stageⅣpancreatic cancer[J].Chin J Endocr Surg, 2009, 2 (2) :95-96. (in Chinese) 吕忠文, 盖保东, 杨冬艳.放射性粒子治疗Ⅳ期胰腺癌[J].中华内分泌外科杂志, 2009, 2 (2) :95-96. [17]WANG JJ, ZHANG FJ.Radioactive particle in tumor:treatment standard[M].Beijing:People's Medical Publishing House, 2016. (in Chinese) 王俊杰, 张福君.肿瘤放射性粒子治疗规范[M].北京:人民卫生出版社, 2016. [18] GAI BD, XIAO ZD, LIU J, et al.Different staging system of pancreatic carcinoma treated with125I seed implantation[J].J Endocr Surg, 2008, 2 (4) :246-248. (in Chinese) 盖保东, 肖中迪, 刘晶, 等.125I放射性粒子治疗不同分期胰腺癌[J].内分泌外科杂志, 2008, 2 (4) :246-248. [19]LI WW, LUO KY.Advances in the brachytherapy with permanent125I seed implantation for pancreatic cancer[J].Med Recapitulate, 2012, 18 (5) :693-696. (in Chinese) 李巍伟, 罗开元.125I粒子组织间永久性植入内放射治疗胰腺癌研究进展[J].医学综述, 2012, 18 (5) :693-696. [20]ISHIKAWA O, OHHIGASHI H, SASAKI Y, et al.Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head[J].Ann Surg, 1988, 208 (2) :215-220. [21]YEO CJ, CAMERON JL, LILLEMOE KD, et al.Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2:randomized controlled trial evaluating survival, morbidity, and mortality[J].Ann Surg, 2002, 236 (3) :355-366. [22]TOL JA, GOUMA DJ, BASSI C, et al.Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma:a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS) [J].Surgery, 2014, 156 (3) :591-600. [23]SUN ZY, LIANG HZ, JIA HP, et al.Ultrasonographic observation on characteristics of the lymph node metastases of primary pancreatic cancer in draining regions[J].Chin J Med Imaging Technol, 2010, 26 (5) :904-906. (in Chinese) 孙志英, 梁会泽, 贾化平, 等.超声观察原发性胰腺癌引流区转移淋巴结[J].中国医学影像技术, 2010, 26 (5) :904-906. [24]National Comprehensive Cancer Network.NCCN Clinical Practice Guidelines in Oncology:Pancreatic Adenocarcinoma, Version 1.2017:MS-11[2017-12-31].www.nccn.org [25]BRUGGE WR, DE WITT J, KLAPMAN JB, et al.Techniques for cytologic sampling of pancreatic and bile duct lesions:The Papanicolaou Society of Cytopathology Guidelines[J].Cytojournal, 2014, 11 (Suppl 1) :2. [26]MICAMES C, JOWELL PS, WHITE R, et al.Lower frequency of peritoneal carcinomatosis in patients with pancreatic cancer diagnosed by EUS-guided FNA vs.percutaneous FNA[J].Gastrointest Endosc, 2003, 58 (5) :690-695. [27]OKASHA HH, NAGA MI, ESMAT S, et al.Endoscopic ultrasound-guided fine needle aspiration versus percutaneous ultrasoundguided fine needle aspiration in diagnosis of focal pancreatic masses[J].Endosc Ultrasound, 2013, 2 (4) :190-193. [28]GAI BD, SHU ZB, DING DY, et al.Clinical analysis of125I seed implantation for pancreatic carcinoma[J].Chin J Bases Clin General Surg, 2007, 14 (5) :582-583. (in Chinese) 盖宝东, 舒振波, 丁大勇, 等.125I放射性粒子治疗胰腺癌[J].中国普外基础与临床杂志, 2007, 14 (5) :582-583. [29] GAI BD, LI QC, YANG DY.Safety analysis of ultrasound guided percutaneous125I radioactive seed interstitial implantation for treatment of pancreatic cancer[J].Chin J Endocr Surg, 2016, 10 (3) :180-181. (in Chinese) 盖保东, 李清春, 杨冬艳.超声引导经皮穿刺125I放射性粒子组织间植入治疗胰腺癌安全性分析[J].中华内分泌外科杂志, 2016, 10 (3) :180-181. [30]WU YM, JIN ZD.Therapeutic effect of endoscopic utrasonography (EUS) implanted125I seeds for advanced stage of pancreatic carcinoma[J].Acta Academiae Med CPAF, 2010, 19 (2) :138-140. (in Chinese) 吴有明, 金震东.超声内镜引导下125I粒子植入组织治疗晚期胰腺癌疗效观察[J].武警医学院学报, 2010, 19 (2) :138-140. [31]XU YJ, LIU M, HE XM, et al.1.0T open MRI-guided125I seeds percutaneous implantation for advanced pancreatic cancer[J].J Shandong Univ:Health Sciences, 2017, 55 (2) :21-25. (in Chinese) 许玉军, 柳明, 何祥萌, 等.1.0T开放型磁共振引导经皮穿刺125I放射性粒子植入治疗晚期胰腺癌[J].山东大学学报:医学版, 2017, 55 (2) :21-25. [32]GUO FX, JIANG YL, JI Z, et al.3D printed template-assisted and computed tomography image-guided125-iodine seed implantation for supraclavicular metastatic tumor:a dosimetric study[J].J Peking Univ:Health Sci, 2017, 49 (3) :506-511. (in Chinese) 郭福新, 姜玉良, 吉喆, 等.3D打印非共面模板辅助CT引导125I粒子植入治疗锁骨上复发转移癌的剂量学研究[J].北京大学学报:医学版, 2017, 49 (3) :506-511. [33] ZHANG HT, DI XM, YU HM, et al.Dose comparison between pre and post operation of125I seeds implantation guided by 3D print tamplate[J].Natl Med J China, 2016, 96 (9) :712-715. (in Chinese) 张宏涛, 底学敏, 于慧敏, 等.3D打印模板引导125I粒子植入术前术后剂量对比[J].中华医学杂志, 2016, 96 (9) :712-715. [34]JI Z, JIANG YL, GUO FX, et al.Dosimetry verification of radioactive seed implantation for malignant tumor assisted by 3D printing individual guide template[J].Chin J Radiol Med Prot, 2016, 36 (9) :662-666. (in Chinese) 吉喆, 姜玉良, 郭福新, 等.3D打印个体化非共面模板辅助放射性粒子植入治疗恶性肿瘤的剂量学验证[J].中华放射医学与防护杂志, 2016, 36 (9) :662-666. [35] JIANG YL, WANG H, JI Z, et al.Computed tomography imageguided and personalized 3D printed template-assisted125-iodine seed implantation for recurrent pelvic tumor:a dosimetric study[J].Chin J Radiat Oncol, 2016, 25 (9) :959-964. (in Chinese) 姜玉良, 王皓, 吉喆, 等.CT引导辅助3D打印个体化非共面模板指导125I粒子治疗盆腔复发肿瘤剂量学研究[J].中华放射肿瘤学杂志, 2016, 25 (9) :959-964. [36]GUO JH, HU XK, TENG GJ.Radioactive particle therapy technology:problems and development[J].Natl Med J China, 2017, 97 (19) :1444-1445. (in Chinese) 郭金和, 胡效坤, 滕皋军.放射性粒子治疗技术行业存在的问题和发展方向[J].中华医学杂志, 2017, 97 (19) :1444-1445. [37]National Comprehensive Cancer Network.NCCN Clinical Practice Guidelines in Oncology:Pancreatic Adenocarcinoma, Version II.2017, PANC-F[2017-12-31].www.nccn.org [38]YIN WB, GU XZ.Radiotherapy of tumo[M].Beijing:Peking Union Medical College Press, 2008:776-782. (in Chinese) 殷蔚伯, 谷铣之.肿瘤放射治疗学[M].北京:中国协和医科大学出版社, 2008:776-782. [39]WANG J, JING Y, LI J, et al.Intraoperative ultrasound-guided iodine-125 seed implantation for unresectable pancreatic carcinoma[J].J Exp Clin Cancer Res, 2009, 28 (1) :88-93. [40] WANG CF, ZHAO P, LI YX, et al.Role of125I seed implantation in treatment of unresectable pancreatic cancer[J].Natl Med J China, 2012, 90 (2) :92-95. (in Chinese) 王成锋, 赵平, 李晔雄, 等.125I粒子植入治疗局部进展期胰腺癌[J].中华医学杂志, 2012, 90 (2) :92-95. [41]WANG J, WANG J, LIAO A, et al.The direct biologic effects of radioactive125I seeds on pancreatic cancer cells PANC-1, at continuous low-dose rates[J].Cancer Biother Radiopharm, 2009, 24 (4) :409-416. [42]GAI BD, HOU RZ, LI QC.Perioperative management of radioactive particles therapy for pancreatic cancer[J].Chin J Endocr Surg, 2010, 4 (3) :196-197. (in Chinese) 盖保东, 侯睿智, 李清春.放射性粒子治疗胰腺癌的术前准备与术后处理[J].中华内分泌外科杂志, 2010, 4 (3) :196-197. [43]LI MW, YIN ZX, HAN GH.The current clinical practice of percutaneous transhepatic biliary drainage for the treatment of malignant biliary obstruction[J].J Intervent Radiol, 2013, 22 (10) :877-880. (in Chinese) 李明武, 殷占新, 韩国宏.经皮肝穿胆道引流术治疗恶性梗阻性黄疸的临床应用现状[J].介入放射学杂志, 2013, 22 (10) :877-880. [44]DU SY, GAI BD, QU J, et al.Comparison of effects of ultrasound-guided implantation of radioative125I particles in treatment of pancreatic cancer between percutaneous puncture and laparotomy[J].J Jilin Univ:Med Edit, 2017, 43 (2) :381-385. (in Chinese) 杜思韵, 盖保东, 屈佳, 等.经皮超声引导与开腹术中超声引导植入放射性125I粒子治疗胰腺癌的效果比较[J].吉林大学学报:医学版, 2017, 43 (2) :381-385. [45] GAI BD, JIN ZT, SHU ZB, et al.Causes analysis of postoperative complications after implantation of radioative125I particles in treatment of pancreatic cancer[J].Chin J Gen Surg, 2007, 22 (11) :873-874. (in Chinese) 盖宝东, 金仲田, 舒振波, 等.125I放射性粒子治疗胰腺癌术后并发症分析[J].中华普通外科杂志, 2007, 22 (11) :873-874. [46]GAI BD, LI YC.Non-operative treatment of pancreatic fistula[J].Chin J Modern Operative Surg, 2002, 6 (12) :311-313. (in Chinese) 盖宝东, 李永超.胰瘘的非手术治疗现状[J].中国现代手术学杂志, 2002, 6 (12) :311-313. [47]TANG Y, YU JP, ZHANG DW.The incidence of pancreatic fistula after125I seed implantation in treatment of advanced pancreatic cancer and the influencing factors[J].J Abdom Surg, 2016, 29 (1) :60-63. (in Chinese) 唐羿, 於建鹏, 张德巍.晚期胰腺癌125I粒子植入后胰瘘发生率及其影响因素分析[J].腹部外科, 2016, 29 (1) :60-63. [48]HUANG HJ, JIANG Y, WU BQ, et al.Complications and prognosis of intraoperative iodine-125 seed implantation therapy in patients with unresectable advanced pancreatic cancer[J].J Hepatopancreatobiliary Surg, 2014, 26 (4) :281-284. (in Chinese) 黄洪军, 江勇, 吴宝强, 等.术中125I放射性粒子植入治疗不能切除晚期胰腺癌的并发症和预后分析[J].肝胆胰外科杂志, 2014, 26 (4) :281-284. [49]LIU Y, WANG YB, DONG JH.Factors for gastroparesis in treatment of post-operative pancreatic cancer patients with125I seed implantation[J].Acad J Chin PLA Med Sch, 2014, 35 (3) :201-203. (in Chinese) 刘洋, 王彦斌, 董家鸿.术中放射性粒子植入治疗胰腺癌术后胃瘫相关因素分析[J].解放军医学院学报, 2014, 35 (3) :201-203. [50]BURRIS HA 3rd, MOORE MJ, ANDERSEN J, et al.Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer:a randomized trial[J].J Clin Oncol, 1997, 15 (6) :2403-2413. [51]GAI BD.Multidisciplinary approach for advanced pancreatic carcinoma[J].Chin J Endocr Surg, 2013, 7 (3) :177-179. (in Chinese) 盖保东.无法手术切除的胰腺癌的综合治疗[J].中华内分泌外科杂志, 2013, 7 (3) :177-179. -
本文二维码
计量
- 文章访问数: 2786
- HTML全文浏览量: 19
- PDF下载量: 622
- 被引次数: 0
下载:
